Moderna Inc (MRNA)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Our last 30 days of resolved calls came true 33% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- Session momentumUp 5.4% on the session+9
- 12-month trend+570% over the past year+10
- 52-week positionPressing 52-week highs+30
- QualityRevenue shrinking (-28% y/y)-11
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 The dominant catalyst here is analyst-driven sentiment, with Citi's verdict and retail momentum headlines outweighing any single fundamental event. Continuation probability over the next few weeks looks low-to-moderate, as the mixed signals (a 703% run alongside a same-day decline) suggest the move is already crowded and vulnerable to profit-taking. Informational only — not financial advice.
- Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads WaterYahoo · 2026-10-01
- Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The BuzzYahoo · 2026-10-01
- Everpure Stock Is September’s Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles InYahoo · 2026-10-01
- If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's ThisYahoo · 2026-10-01
- The Top HealthTech Questions Landing On Our DesksSeekingAlpha · 2026-10-01
Any AI summary is an interpretation of public news, not advice or a price target.